Unlike highly visual psychedelics like DMT, 5-MeO-DMT is described as a non-visual experience. It rapidly blasts the user into a state of 'raw consciousness' where they must completely surrender their ego and all attachments to avoid panic, ultimately leading to unimaginable bliss and euphoria.

Bryan Johnson's 'Blueprint' project, initially focused on interventions like diet and exercise, now includes psychedelics. He views them as a rejuvenation protocol for their potential to create youthful brain patterns and induce a metabolic reset, moving beyond their typical use for depression or anxiety.

Psychedelics disrupt normal brain patterns, which can be powerful for breaking out of neurobiological ruts in middle age. However, using them during the already chaotic and plastic period of brain development in one's 20s may be unnecessarily risky before the brain is 'fully cooked.'

Psychedelics may treat trauma by reducing activity in the brain's outer cortex (responsible for language, planning). This shifts consciousness to deeper regions like the insular cortex, allowing for profound insights and self-compassion without the usual cognitive filters of guilt and blame.

Psychedelics don't erase traumatic memories. Their therapeutic power comes from inducing a massive perspective shift, allowing the individual to view the same event through a completely new and less threatening lens. This insight suggests most psychological suffering is a perspective problem.

The right hemisphere of the brain doesn't define a separate "you." It experiences the world as a unified whole, integrating all sensory input into one big picture. This is the neurological basis for "flow states" or feelings of transcendence, where the boundary between self and the world dissolves.

After age 25, the brain stops changing from passive experience. To learn new skills or unlearn patterns, one must be highly alert and focused. This triggers a release of neuromodulators like dopamine and epinephrine, signaling the brain to physically reconfigure its connections during subsequent rest.

Bryan Johnson's quantified experiments with psilocybin revealed a surprising 'first in human' observation: it triggered a systemic metabolic reset. His blood glucose control improved from the 99.5th to the 99.9th percentile, and his gut microbiome also changed, suggesting effects far beyond the brain.

As AI accelerates the pace of global change, human adaptability becomes a critical asset. Psychedelics, by breaking down rigid mental models and enhancing neuroplasticity, could be a key tool for helping individuals maintain the psychological flexibility required to navigate and thrive in a rapidly evolving world.